The current status and prospects of radiomics in the clinical application of renal cell carcinoma
10.3760/cma.j.cn112330-20240408-00175
- VernacularTitle:肾癌影像组学的临床应用现状与展望
- Author:
Ben HE
1
;
Hui ZHUO
;
Wei TANG
Author Information
1. 成都市第三人民医院泌尿外科/西南交通大学附属医院泌尿外科，成都 610031
- Publication Type:Journal Article
- Keywords:
Carcinoma, Renal cell;
Radiomics;
Artificial intelligence;
Computed tomography
- From:
Chinese Journal of Urology
2024;45(10):796-799
- CountryChina
- Language:Chinese
-
Abstract:
Radiomics refers to the use of multiple techniques to extract high-throughput quantitative features from medical images to improve the accuracy of imaging diagnosis and prognosis prediction, and to guide clinical decision making. In recent years, more and more studies have begun to explore the application of radiomics in the diagnosis and treatment of renal cell carcinoma (RCC), expanding its guiding role in the clinical practice of RCC. In the field of RCC, radiomics is mainly used in the diagnosis and differential diagnosis of RCC, predicting the pathological characteristics, the efficacy and prognosis, and molecular biomarkers of RCC gene mutations. This article briefly introduces the basic process of radiomics, and focuses on a review of the clinical application status and research progress of radiomics in RCC.
